Ticker Details
Heron Therapeutics, Inc. Heron Therapeutics Inc is a biotechnology company, developing products to address unmet medical needs. It is developing novel, patient-focused solutions that apply its science and technologies to already-approved pharmacological agents.
IPO Date:	January 23, 2014
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$216.37M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.37 | 3.06%
Avg Daily Range (30 D):	$0.03 | 2.60%
Avg Daily Range (90 D):	$0.03 | 2.48%

Institutional Daily Volume
Avg Daily Volume:	1.27M
Avg Daily Volume (30 D):	1.27M
Avg Daily Volume (90 D):	1.6M

Trade Size
Avg Trade Size (Sh.):	164
Avg Trade Size (Sh.) (30 D):	354
Avg Trade Size (Sh.) (90 D):	308

Institutional Trades
Total Institutional Trades:	3,469
Avg Institutional Trade:	$1.58M
Avg Institutional Trade (30 D):	$.77M
Avg Institutional Trade (90 D):	$.99M
Avg Institutional Trade Volume:	.13M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$2.03M
Avg Closing Trade (30 D):	$1.57M
Avg Closing Trade (90 D):	$1.57M
Avg Closing Volume:	180.87K

News

Oct 29, 2025 @ 9:58 PM Heron Therapeutics Announces Appointment of Thomas... Source: Craig Collard

Oct 29, 2024 @ 8:05 PM Heron Therapeutics to Report Third Quarter 2024 Fi... Source: Prnewswire

Sep 17, 2024 @ 10:00 AM Chemotherapy Induced Nausea and Vomiting Treatment... Source: Fact.Mr

Jul 2, 2024 @ 12:43 PM Merck (MRK) Gets Exclusive Rights to Opevesostat F... Source: Zacks Equity Research

Jul 1, 2024 @ 2:31 PM FDA Rejects Rocket's (RCKT) Gene Therapy BLA for R... Source: Zacks Equity Research

Financials
	TTM	Q2 2025	Q1 2025
Basic EPS	$-.1	$-.02	$.02
Diluted EPS	$-.1	$-.02	$.01
Revenue	$38.21M	$37.2M	$38.9M
Gross Profit	$26.3M	$27.34M	$30.45M
Net Income / Loss	$-17.5M	$-2.38M	$2.64M
Operating Income / Loss	$-4.09M	$-1.64M	$3.15M
Cost of Revenue	$11.91M	$9.86M	$8.46M
Net Cash Flow	$26.55M	$-2.75M	$-6.53M
PE Ratio

Splits
Jan 13, 2014	1:20
May 25, 2007	1:4